NeuroBo Pharmaceuticals Operating Income 1970-1969 | MTVA
NeuroBo Pharmaceuticals operating income from 1970 to 1969. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
NeuroBo Pharmaceuticals Annual Operating Income
(Millions of US $) |
NeuroBo Pharmaceuticals Quarterly Operating Income
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
